全文获取类型
收费全文 | 350篇 |
免费 | 9篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 37篇 |
妇产科学 | 9篇 |
基础医学 | 17篇 |
口腔科学 | 8篇 |
临床医学 | 20篇 |
内科学 | 109篇 |
皮肤病学 | 2篇 |
神经病学 | 16篇 |
特种医学 | 9篇 |
外科学 | 42篇 |
综合类 | 5篇 |
预防医学 | 4篇 |
眼科学 | 29篇 |
药学 | 18篇 |
肿瘤学 | 32篇 |
出版年
2023年 | 2篇 |
2022年 | 6篇 |
2021年 | 13篇 |
2020年 | 9篇 |
2019年 | 5篇 |
2018年 | 13篇 |
2017年 | 10篇 |
2016年 | 18篇 |
2015年 | 15篇 |
2014年 | 27篇 |
2013年 | 27篇 |
2012年 | 37篇 |
2011年 | 27篇 |
2010年 | 13篇 |
2009年 | 16篇 |
2008年 | 22篇 |
2007年 | 24篇 |
2006年 | 23篇 |
2005年 | 23篇 |
2004年 | 13篇 |
2003年 | 3篇 |
2002年 | 4篇 |
2000年 | 1篇 |
1998年 | 3篇 |
1997年 | 5篇 |
1996年 | 2篇 |
排序方式: 共有361条查询结果,搜索用时 15 毫秒
81.
Ceren Kizmazoglu Hasan Emre Aydin Ismail Ertan Sevin Orhan Kalemci Nurullah Yüceer Metin Ant Atasoy 《Journal of Korean Neurosurgical Society》2015,58(6):508-512
BackgroundCerebral ischemia is as a result of insufficient cerebral blood flow for cerebral metabolic functions. Resveratrol is a natural phytoalexin that can be extracted from grape''s skin and had potent role in treating the cerebral ischemia. Apoptosis, a genetically programmed cellular event which occurs after ischemia and leads to biochemical and morphological changes in cells. There are some useful markers for apoptosis like Bcl-2, bax, and p53. The last reports, researchers verify the apoptosis with early markers like Annexin V.MethodsWe preferred in this experimental study a model of global cerebral infarction which was induced by bilateral common carotid artery occlusion method. Rats were randomly divided into 4 groups : sham, ischemia-reperfusion (I/R), I/R plus 20 mg/kg resveratrol and I/R plus 40 mg/kg resveratrol. Statistical analysis was performed using Sigmastat 3.5 ve IBM SPSS Statistics 20. We considered a result significant when p<0.001.ResultsAfter administration of resveratrol, Bcl-2 and Annexin levels were significantly increased (p<0.001). Depending on the dose of resveratrol, Bcl2 levels increased, p53 levels decreased but Annexin V did not effected. P53 levels were significantly increased in ishemia group, so apoptosis is higher compared to other groups.ConclusionIn the acute period, Annexin V levels misleading us because the apoptotic cell counts could not reach a certain level. Therefore we should support our results with bcl-2 and p53. 相似文献
82.
83.
84.
85.
Nuriye Yıldırım Özdemir Hüseyin Abalı Berna Öksüzoğlu Burçin Budakoglu Doğan Uncu Tunç Güler Hatice Odabaşı Nurullah Zengin 《Medical oncology (Northwood, London, England)》2010,27(3):680-684
Patients with advanced gastric carcinoma have still had bad prognosis despite advances in the modern treatment era. Docetaxel,
cisplatin, 5-fluorouracil (DCF) is effective, but highly toxic regimen for advanced cases. In this study, we modified the
standard doses of DCF (mDCF) to evaluate the effectiveness and side effects. From July 2005 to July 2008, 37 advanced gastric
cancer patients treated with at least one course of mDCF protocol as first-line treatment were included. The mDCF protocol
included 60 mg/m2 docetaxel and cisplatin for 1 day and 600 mg/m2/day, 5-flourouracil infusion for 5 days, repeated every 3 weeks. No patients used prophylactic granulocte -colony stimulating
factor. Of the patients, 28 were male and nine were female; the median age was 53 (23–65) years. Of them, 83.8% received at
least four courses of chemotherapy and 64.9% completed the preplanned six courses of treatment. Eleven (29.7%) of those patients
who received mDCF in the first-line treatment used the FOLFIRI (5-FU, folinic acit, irinotekan) regimen for the second-line
treatment. Response rates were evaluated according to RECIST criteria in 30 out of 37 patients. The median follow-up time
was 7.1 months. The longest follow-up time was 19.9 months. Two patients (5.4%) had complete response, nine (21.6%) had partial
response, and 14 (37.9%) had stabilized disease; overall, the disease was controlled in 25 patients (64.9%) whereas five patients
(13.5%) had progression. Median time to progression was 6.7 months and overall survival was 10 months. The assessment of patients
for grade 3–4 toxicity revealed that while 5.4% had anemia and 8.1% had neutropenia, 5.4% nausea and 5.4% diarrhea. Neutropenic
fever developed in two patients, requiring hospitalization. G-CSF was used in three patients. Two patients with neutropenic
fever and two with severe anemia (total number 4; 10.8%) received delayed chemotherapy. Dose reduction was required in four
patients (10.8%), one due to neutropenia, one due to nephrotoxicity, and two due to nausea. No patient died due to chemotherapy
toxicity. This retrospective study suggested that mDCF might have comparable efficacy with classical DFC, with better toxicity
profile. However, its small size and retrospective nature should be considered when interpreting the results. 相似文献
86.
G?nül ?atl? Ayhan Abac? Ahmet An?k Handan Güleryüz Erdener ?zer ?rfan ?cal Nurullah Yüceer Kamer Mutafo?lu 《Journal of clinical research in pediatric endocrinology》2014,6(3):183-186
Central precocious puberty (CPP) is caused by premature activation of the hypothalamo-pituitary-gonadal axis. More than 50% of boys with CPP have an identifiable etiology. Hypothalamic hamartoma (HH), hydrocephalus, tumors, infections, congenital defects, ischemia, radiation, or injury of the brain are the most common causes of secondary CPP. In this report, we present the case of a 2 years and 9 months old male patient who had a 30x40 mm contrast-enhancing suprasellar mass and was histopathologically diagnosed with giant HH. However, since HHs are designated as non-enhancing masses, considering the possibility of an incomplete diagnosis of a glial tumor, the patient was followed up. Clinical and radiological follow-up revealed stable findings with no evidence of tumor growth until the third year after surgery when he presented with neurological deficit due to the rapid growth of the suprasellar mass. After the second surgery, histopathological examination of the biopsy specimen revealed the lesion to be a juvenile pilocytic astrocytoma (PA). The concomitance of HH and juvenile PA is very rare. To our knowledge, this is the first report of a patient with concomitant juvenile PA and HH who developed CPP and did not have gelastic epilepsy despite the rapidly growing giant mass. 相似文献
87.
Sari I Akar S Secil M Birlik M Kefi A Onen F Celebi I Akkoc N 《Rheumatology international》2005,25(6):472-474
Henoch-Schönlein purpura (HSP) belongs to the category of systemic small-vessel vasculitis. Although long-term outcome is generally good, serious complications may occur. Thrombosis and priapism have been reported only as extremely rare complications of HSP. We describe a 37-year-old man who developed recurrent thrombotic events shortly after he had been diagnosed as having HSP. Although he had additional risk factors for thrombosis, such as prothrombin G20210A mutation and use of celecoxib before the last episode, temporal relation of the thrombotic attacks to the onset of HSP suggest that the disease itself may lead to a prothrombotic state. This case is the first adult HSP patient with priapism, which probably developed secondary to thrombosis of the dorsal penile vein. 相似文献
88.
Mutlu Dogan Tulay Eren Nuriye Ozdemir Can L. Cigirgan Nurullah Zengin 《Saudi Journal Of Gastroenterology》2015,21(5):320-324
Background/Aims:
The association between platelet–lymphocyte ratio (PLR), neutrophil–lymphocyte ratio (NLR), and survival with response rates were evaluated in metastatic gastric cancer (MGC).Patients and Methods:
MGC patients on firstline modified docetaxel/cisplatinum/5-fluorourasil [mDCF; docetaxel 60 mg/m2 (days 1–5), cisplatin 60 mg/m2 (day 1), 5FU 600 mg/m2 (days 1–5), q3w] were evaluated retrospectively. The cutoff values were 160 for PLR and 2.5 for NLR. Progression-free survival (PFS) and overall survival (OS) were estimated for group I (PLR >160), group II (PLR ≤ 160), group III (NLR ≥ 2.5), group IV (NLR < 2.5), group V (PLR > 160 and NLR ≥ 2.5), group VI (PLR ≤ 160 and NLR <2.5), and group VII [VIIa (PLR > 160 and NLR < 2.5) and VIIb (PLR ≤160 and NLR ≥ 2.5)].Results:
One hundred and nine MGC patients were evaluated for basal hematological parameters and survival analysis, retrospectively. Most of the patients were male in their fifties with grade III adenocarcinoma (62.9%) and liver metastasis (46.7%). Patients with PLR > 160 and/or NLR ≥ 2.5 had significantly shorter PFS and OS (P = 0.04, 0.01, 0.019, and P = 0.003, 0.002, 0.000, respectively).Conclusion:
High PLR (> 160) and/or NLR (≥ 2.5) seem to be poor prognostic factors in MGC. 相似文献89.
90.
Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey 总被引:3,自引:0,他引:3
Onen F Akar S Birlik M Sari I Khan MA Gurler O Ergor A Manisali M Akkoc N 《The Journal of rheumatology》2008,35(2):305-309
OBJECTIVE: To determine the prevalence of ankylosing spondylitis (AS) and related spondyloarthritides (SpA) in an adult urban population of Izmir, Turkey. METHODS: A survey was conducted of 2887 subjects aged 20 years or over, selected by cluster sampling. Those who responded positively to the screening questions were contacted by 2 rheumatologists and evaluated in detail to establish presence of AS (modified New York criteria) or related SpA (ESSG criteria). RESULTS: In the initial screening, 2835 subjects participated; 422 were considered screening-positive and a telephone interview was done with 328 (78%). Based on their clinical history, 145 subjects were invited to the hospital and 120 (83%) agreed to do so. After detailed evaluation, 31 subjects were classified as having SpA (including 14 with AS). The age- and sex-adjusted prevalence was estimated to be 0.49% for AS (95% CI 0.26-0.85), and 1.05% for SpA (95% CI 0.70-1.50). The prevalence of AS was 0.54% in men (95% CI 0.19-1.20) and 0.44% in women (95% CI 0.19-0.88), and that of SpA was 0.88% in men (95% CI 0.42-1.59) and 1.22% in women (95% CI 0.73-1.89). CONCLUSION: This epidemiological study suggests a high prevalence (0.49%) of AS in an adult urban population from western Turkey, which equals that of rheumatoid arthritis in the same population. The overall prevalence of SpA, including AS, was 1.05%. A minimal male predominance was noted among AS patients, which disappeared among the whole group of patients with SpA. 相似文献